Midkine (Human, 60 – 121)

4299-v 0.1 mg | 255.00 EUR

Ala – Asp – Cys – Lys – Tyr – Lys – Phe – Glu – Asn – Trp – Gly – Ala – Cys – Asp – Gly – Gly – Thr – Gly – Thr – Lys – Val – Arg – Gln – Gly – Thr – Leu – Lys – Lys – Ala – Arg – Tyr – Asn – Ala – Gln – Cys – Gln – Glu – Thr – Ile – Arg – Val – Thr – Lys – Pro – Cys – Thr – Pro – Lys – Thr – Lys – Ala – Lys – Ala – Lys – Ala – Lys – Lys – Gly – Lys – Gly – Lys – Asp

Synthetic Product bonds between Cys⁶²– Cys⁹⁴, and Cys⁷²– Cys¹⁰⁴

The purity is guaranteed to be higher than 99% by HPLC

Heparin-Binding Growth / Differentiation Factor active Domain
(Neurotrophic Factor, Neurite Outgrowth-Promoting Factor)
Plasminogen Activator Activity Enhancer

References:

1. J-i. Tsutsui, K. Uehara, K. Kadomatsu, S. Matsubara and T. Muramatsu, Biochem. Biophys. Res. Commun, 176, 792 (1991) (Original)
2. H. Muramatsu, T. Inui, T. Kimura, S. Sakakibara, X.-j. Song, H. Maruta and T. Muramatsu, Biochem. Biophys. Res. Commun, 203, 1131 (1994) (Pharmacol.)
3. T. Inui, J. Bódi, S. Kubo, H. Nishio, T. Kimura, S.Kojima, H. Maruta, T. Muramatsu and S. Sakakibara, J. Peptide Sci., 2, 28 (1996) (Chem. Synthesis)
4. G.S.P. Yu, J. Hu and H. Nakagawa, Neurosci. Lett., 254, 128 (1998) (Pharmacol.; Inhibition of b-amyloid cytotoxicity)

This peptide is distributed through Peptide Institute, Inc. under the license of Prof. Takeshi Muramatsu. The use for any other purpose than research is strictly prohibited.